Hi,
This AFR article appears on other biotech company boards. GTG is not discussed specifically but its market cap and cash burn end point appears in the table at the end. Unfortunately, the cash at bank is at the end of June and does not include the funds from cap raising.
http://www.afr.com/p/personal_finance/portfolio/biotechs_making_steady_recovery_sZ6Y3EkaQduEbnPbuoXviK
GTG would be looking a little weak without the funds from the cap raising.
Regards.
gtg and the biotech sector
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add GTG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.252M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 95515 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 52501 | 2 |
View Market Depth
| Last trade - 10.04am 25/07/2024 (20 minute delay) ? |
| GTG (ASX) Chart |
Day chart unavailable